New Device May Improve Lazy Eye
Research Centre: Queensland Eye Institute Foundation
Location: 140 Melbourne Street, South Brisbane, 4101
Lead Doctor: Prof. Mark Radford
Ethics Committee: This study has been reviewed and approved by the RANZCO Human Research Ethics Committee
Amblyopia, also known as “Lazy Eye” is a condition that affects 3% of the population. The primary aim of this trial is to assess whether 6 weeks of treatment with a prototype device can result in significant reduction in “Lazy Eye”.
Participants will wear the head-mounted prototype device for a total of no less than 30 minutes per day, morning and evening for 6 weeks.
The study requires participants between 8 and 50 years of age who have “Lazy Eye” with a history of previous (not current) treatment for the condition. Participants are required to attend at least 5 study visits, may see an improvement in their health, and will be helping advance medical research.
- You may experience an improvement in “Lazy Eye” symptoms
- You will be helping to advance medical research.
- If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
- Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
- Qualified health professionals will monitor your health as it relates to the study.
Who Can Participate?
- Men and women between 8 and 50 years of age who suffer from “Lazy Eye”
- Have previously been treated for their “Lazy Eye”
- Able to attend 5 study visits at the research site over approximately 6 months